Literature DB >> 689075

Analysis of the diversity of murine antibodies to dextran B1355. III. Idiotypic and spectrotypic correlations.

D Hansburg, R M Perlmutter, D E Briles, J M Davie.   

Abstract

Examination of 19 S and 7 S anti-alpha(1 leads to 3) dextran (Dex) antibodies by serological assays and isoelectric focusing (IEF) has revealed substantial variation of idiotypic and spectrotypic expression between individuals of the same genotype. 7 S antibodies appeared to be more heterogeneous than 19 S by both methods. A strong, but complex, association was found between the IEF patterns of 19 S and 7 S anti-Dex antibodies and their expression of the idiotypic determinant(s) common to both the M104 and J558 dextran-binding myeloma proteins. However, no such relationship was found between the IEF pattern and the expression of idiotypic determinant(s) unique to the M104 myeloma protein. Rather, indistinguishable spectrotypes from different individuals have widely differing levels of expression of the determinant. In addition, this determinant(s) may be present on different spectrotypes of the same isotype. Both the M104 and J558-specific idiotypes were found on antibodies of the IgG3 subclass as well as in pools containing predominantly the IgG2a subclass. These data confirm and extend the picture of substantial structural variation among the antibodies comprising a response of restricted heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 689075     DOI: 10.1002/eji.1830080512

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Limiting CDR-H3 diversity abrogates the antibody response to the bacterial polysaccharide α 1→3 dextran.

Authors:  Tamer I Mahmoud; Harry W Schroeder; John F Kearney
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

Review 2.  Molecular characteristics of anti-polysaccharide antibodies.

Authors:  C Bona
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Idiotypic specificities and cross-reactivities of rabbit antibodies to human antidextran.

Authors:  I M Outschoorn
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

4.  Terminal deoxynucleotidyl transferase is required for an optimal response to the polysaccharide α-1,3 dextran.

Authors:  Tamer I Mahmoud; John F Kearney
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

5.  Contribution of murine IgG Fc regions to antibody binding to the capsule of Burkholderia pseudomallei.

Authors:  Michael J Dillon; Rachael A Loban; Dana E Reed; Peter Thorkildson; Kathryn J Pflughoeft; Sujata G Pandit; Paul J Brett; Mary N Burtnick; David P AuCoin
Journal:  Virulence       Date:  2016-04-20       Impact factor: 5.882

6.  Analysis of human anti-diphtheria antibodies by isoelectric focusing: evidence for restricted clonal heterogeneity of anti-fragment A antibodies.

Authors:  C D Morrow; E M Macy; R H Stevens
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

7.  Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect.

Authors:  R M Perlmutter; M Nahm; K E Stein; J Slack; I Zitron; W E Paul; J M Davie
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

8.  Structural correlates of cross-reactive and individual idiotypic determinants on murine antibodies to alpha-(1 leads to 3) dextran.

Authors:  B Clevinger; J Schilling; L Hood; J M Davie
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

9.  Loss of an individual idiotype on chemical modification. A strategy for assigning idiotypic determinants.

Authors:  J Dickerman; B Clevinger; B Friedenson
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

10.  Induction of a cross-reactive idiotype dextran-positive antibody response in two IgH-Cb mouse strains treated with anti-J558 cross-reactive idiotype antibodies.

Authors:  J Pène; F Bekkhoucha; C Desaymard; H Zaghouani; M Stanislawski
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.